ArticleCancers2022

The Kinetics of FMS-Related Tyrosine Kinase 3 Ligand (Flt-3L) during Chemoradiotherapy Suggests a Potential Gain from the Earlier Initiation of Immunotherapy.

Łukasz Kuncman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.